TGM2 and cancer: In particular, TGM2 alternative splicing emerges as one of the mechanisms that increase cell-type-dependent TG2 functional complexity, and whose dysregulation seems to play a role in several pathologies including cancer and neurodegeneration [60,64,183,184].